
Glaucoma is the leading cause of irreversible blindness globally, affecting over 80 million people, with the majority undiagnosed in low- and middle-income settings. Intraocular pressure reduction through topical medications, laser therapy, and surgery remains the only proven treatment strategy. Neuroprotective agents, sustained-release drug delivery, and artificial intelligence-assisted screening are advancing through development.
Loading articles...
